DeepMed Research

RTOG Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.rtog.org

Clinical Trials

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Drug: Oral antiandrogen
Drug: Dexamethasone
Radiation: Radiation therapy
Drug: Prednisone
Drug: LHRH agonist
Drug: docetaxel

First Posted Date: 2006-02-07

Last Posted Date: 2022-06-21

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 612

Registration Number: NCT00288080

Locations: 🇺🇸
DeCesaris Cancer Institute at Anne Arundel Medical Center, Annapolis, Maryland, United States
🇺🇸
St. Agnes Hospital Cancer Center, Baltimore, Maryland, United States
🇺🇸
Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland, Ohio, United States

and more 251 locations

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 3

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: cisplatin
Drug: cetuximab
Radiation: Accelerated Fractionation by Concomitant Boost
Radiation: Intensity-modulated radiation therapy

First Posted Date: 2005-12-15

Last Posted Date: 2022-06-14

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 940

Registration Number: NCT00265941

Locations: 🇺🇸
Billings Clinic - Downtown, Billings, Montana, United States
🇺🇸
Sutter Solano Medical Center, Vallejo, California, United States
🇺🇸
Cancer Care Center at John Muir Health - Concord Campus, Concord, California, United States

and more 366 locations

Radiation Therapy in Treating Patients With Liver Metastases

Phase 1

Completed

Conditions: Metastatic Cancer

Interventions: Radiation: radiation therapy

First Posted Date: 2005-11-21

Last Posted Date: 2015-11-17

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 26

Registration Number: NCT00255814

Locations: 🇺🇸
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States
🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦
McGill Cancer Centre at McGill University, Montreal, Quebec, Canada

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: Temozolomide
Radiation: Radiation therapy

First Posted Date: 2005-06-14

Last Posted Date: 2024-07-08

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 136

Registration Number: NCT00114140

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸
Integrated Community Oncology Network, Jacksonville Beach, Florida, United States
🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

and more 44 locations

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Phase 3

Terminated

Conditions: Head and Neck Cancer

Interventions: Drug: cisplatin
Biological: filgrastim
Drug: docetaxel
Drug: paclitaxel
Drug: fluorouracil
Radiation: radiation therapy

First Posted Date: 2005-06-08

Last Posted Date: 2013-07-02

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 15

Registration Number: NCT00113399

Locations: 🇺🇸
Lynn Regional Cancer Center at Boca Raton Community Hospital - Main Center, Boca Raton, Florida, United States
🇺🇸
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford, Salem, Ohio, United States
🇺🇸
AnMed Health Cancer Center, Anderson, South Carolina, United States

and more 122 locations

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Phase 3

Terminated

Conditions: Lung Cancer

Interventions: Biological: filgrastim
Biological: pegfilgrastim
Drug: cisplatin
Drug: docetaxel
Procedure: adjuvant therapy
Procedure: conventional surgery
Procedure: neoadjuvant therapy
Radiation: radiation therapy

First Posted Date: 2005-06-08

Last Posted Date: 2013-06-28

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 19

Registration Number: NCT00113386

Locations: 🇺🇸
CCOP - Greenville, Greenville, South Carolina, United States
🇺🇸
CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸
St. Agnes Hospital Cancer Center, Baltimore, Maryland, United States

and more 73 locations

Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: irinotecan hydrochloride
Drug: temozolomide
Procedure: adjuvant therapy
Radiation: radiation therapy

First Posted Date: 2004-12-09

Last Posted Date: 2014-01-24

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 170

Registration Number: NCT00099125

Locations: 🇺🇸
Cancer Center at St. Clair Memorial Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
Providence Holy Cross Cancer Center, Mission Hills, California, United States
🇺🇸
Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States

and more 115 locations

Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Induction Carboplatin
Drug: Induction Paclitaxel
Procedure: Resection
Drug: Consolidation Carboplatin
Radiation: Radiation Therapy
Drug: Consolidation Paclitaxel

First Posted Date: 2004-11-09

Last Posted Date: 2019-09-18

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 60

Registration Number: NCT00096226

Locations: 🇺🇸
St. Luke's Cancer Network at St. Luke's Hospital, Bethlehem, Pennsylvania, United States
🇺🇸
Leo W. Jenkins Cancer Center at ECU Medical School, Greenville, North Carolina, United States
🇺🇸
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States

and more 19 locations

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: paclitaxel
Radiation: radiation therapy

First Posted Date: 2004-09-13

Last Posted Date: 2013-11-13

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 122

Registration Number: NCT00003591

Locations: 🇺🇸
Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States
🇺🇸
MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States
🇺🇸
CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

and more 231 locations

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Radiation: High Dose brachytherapy boost
Radiation: External beam radiotherapy

First Posted Date: 2004-09-09

Last Posted Date: 2020-08-10

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 129

Registration Number: NCT00091390

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸
OSF St. Francis Medical Center, Peoria, Illinois, United States
🇺🇸
Cancer Care Consultants Medical Associates at Daniel Freeman Memorial Hospital, Inglewood, California, United States

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy